Pipeline of Immune Engagers

About T-Cypher Bio

T-Cypher Bio is a private, preclinical-stage biotech leveraging a proprietary data-driven platform to discover novel immune targets and develop transformative immune engagers for oncology and autoimmunity. The company's core approach integrates high-throughput experimental biology with computational analysis of massive datasets to uncover hidden biological connections related to immune surveillance. Founded in Cambridge, UK, and now with an operational site in Oxford, T-Cypher is building a diverse pipeline of biologics against novel targets. The company is pre-revenue and focused on advancing its platform and pipeline through internal R&D.

Therapeutic Areas